Arena Pharmaceuticals Inc (ARNA)

Business: Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide.

IPO Date: 28-Jul-2000

Pres & CEO: Mr. Amit D. Munshi M.B.A.

Exec. VP & CFO: Ms. Laurie D. Stelzer

Listing: NASDAQ: ARNA

Country: United States

Headquarters: Park City, UT

Website: https://www.arenapharm.com

Market cap: $6,165.32 Mln

Revenue (TTM): $-3.48 Mln

Earnings (TTM): $-616.43 Mln

Cash: $550.47 Mln

Total Debt: $41.21 Mln

Insider's Holding: 0.27%

Liquidity: Low

52 Week range: $45.50 - 100.00

Shares outstanding: 61,659,400

10 Years Aggregate:

• CFO: $-668.17 Mln
• EBITDA: $-936.14 Mln
• Net Profit: $-1,040.33 Mln